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The West Nile Virus (WNV) is the most widespread 
arthropod-borne virus infection in the world [1]. This 
mosquito-transmitted microrganism is amplified in 
birds; mammals (human and horses) are just only dead-
end hosts [2]. In recent decades, this disease, which 
prevails in tropical regions of world, is becoming an 
emerging issue with outbreaks in a certain number of 
European countries including Italy, Hungary, Romania 
and Greece [2]. Data from European Centre for Dis-
ease Prevention and Control (ECDC) reported 220 hu-
man cases of WNV in 2014, 315 in 2015, 225 in 2016 
and 204 in 2017 [3]. 
However, it should be noted that 2018 has been an 
unusual WNV transmission season in Europe in general 
and in Italy specifically. Indeed, as of 25 October 2018, 
EU Member States have reported 1460 human cases, 
with Italy (n = 550) to the top of  the figures, followed 
by Greece (n = 307), Romania (n = 276), Hungary (n 
= 212), Croatia (n = 53), France (n = 24), Austria (n = 
19), Bulgaria (n = 14), Slovenia (n = 3) and the Czech 
Republic (n = 2) [4]. Cases are both imported and in-
digenous and this is depicted as an emerging public 
health threat. To date, 170 deaths due to WNV infec-
tion have been reported in Italy (n = 44), Greece (n = 
42), Romania (n = 42), Serbia (n = 35), Kosovo (n = 
3), Bulgaria (n = 2), the Czech Republic (n = 1) and 
Hungary (n = 1). 
Transmission of WNV to humans is mainly through 
the bite of an affected mosquito, which in Europe is 
the common house Culex pipiens mosquito [1] and the 
reoccurrence of WNV infection in the same places over 
the years could be a sign of the endemic nature of the 
disease [5]. In addition, transmission is also possible 
through infected blood and blood components, tissues 
and cells, and organ transplants. Cases of vertical trans-
placental mother-to-child transmission and breastfeed-
ing have been also reported [6]. 
In occupational settings, the transmission of this 
infection has been documented in entomologists col-
lecting mosquitoes for surveillance [7]; in a veterinary 
student after performing an autopsy on a Welsh pony 
and in laboratory-workers after accidental percutane-
ous inoculation [8, 9].
Paradoxically, a possible matter of concern is due to 
the fact that infected humans are generally asymptom-
atic or are reporting, in 15-20% of the cases, flu-like 
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Abstract
In these days, the West Nile virus (WNV), which is the most widespread arthropod-
borne virus infection in the world, is an emerging issue in Europe, wherein 2018, partial 
figures (until 25 October) showed a number of WNV infection cases more than doupled 
in comparison with previous five years. This mosquito-transmitted disease is surely a 
challenge for policymakers, but it is an occupational hazard for outdoor workers, as well. 
Occupational medicine is a public health discipline based on the principles of epidemi-
ology. Therefore, we argue that addressing the WNV hazard may be an opportunity for 
integrating the occupational health practice with public health activities to boost their 
respective preventive strategies.  
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symptoms. Consequently, the disease is often unrecog-
nized. According to the US CDC, only less than 1% of 
those infected develop a serious, sometimes fatal, neu-
rologic illness [9], and mortality is generally associated 
with older age groups, pregnancy, immunodeficiency 
or co-morbidities [6]. The occurrence of epidemics is 
therefore often reconstructed from these sentinel cases. 
However, due to the low prevalence of cases that are 
being diagnosed and the outdoor widespread dissemi-
nation of the common mosquito, it is also likely that the 
true prevalence rate of WNV infection may be under-
estimated in both general and occupational population. 
Outdoor workers may be exposed to many types of 
biological hazards including vector-borne diseases, ven-
omous wildlife and insects, and poisonous plants [9]. 
Exposure to vector-borne diseases depends on type of 
work, geographic region, season, and duration of time 
workers are outside [10]. Employers must be aware of 
the risk and must assess this type of biological hazard 
that may be dangerous to many categories of workers 
such as farmers, foresters, landscapers, groundskeepers, 
gardeners, painters, roofers, pavers, construction work-
ers, and so on.
Mosquito-transmitted diseases like WNV and others, 
therefore, should not be only considered as a hazard 
for general population and an issue of public health, 
but they should be viewed as a specific occupational 
risk to be addressed in the framework of occupational 
and health safety legislation, as well. Employers should 
specifically evaluate this biological hazard, especially in 
those regions of European countries where epidemio-
logical data provided by public health surveillance sys-
tems have been showing an increasing trend of WNV 
infection cases.
The risk assessment should focus on the type of work-
place, season, time of the day and geographical zone 
where employee do their job. Data obtained by the 
surveillance systems of public health should be used as 
well. Employers must provide outdoor employees with 
specific preventive measures such as protective cloth-
ing, mosquito repellents and permethrin-containing 
products to apply on clothing, as well as specific train-
ing for workers and interventions at worksites, the so-
called primary measures, to eliminate standing water 
and carry out disinfestations when needed [10]. Work-
ers’ education focused on prevention of bites of mos-
quitoes and insects could be a workplace measure of 
prevention. These measures should be firstly individu-
ated, planned and managed within the framework of 
the occupational risk assessment process. 
Finally, medical health surveillance should be con-
ducted, with pre-assignment and periodical medical ex-
aminations, for the early detection of effects on health 
of workers exposed to this biological hazard. Occu-
pational health surveillance is a secondary prevention 
measure required by national law whenever workers are 
liable to be exposed to occupational risks that primary 
measures cannot eliminate [11]. In this case, it should 
focus on potential individual restrictions in case of old-
er, pregnant, or immunodeficient workers, especially 
when they are affected by comorbidities. However, the 
aim of occupational health surveillance is not only to 
check the worker’s fitness to work, but also to evaluate 
and to provide the entire evaluation process with epi-
demiological information, which may be useful for risk 
prevention [11]. 
In 2013, the ECDC has released a technical report 
containing the “WNV risk assessment tool” that uses 
information gathered through the surveillance mecha-
nisms set up by public health stakeholders to ascertain 
the level of risk for human transmission of WNV within 
an area. This instrument categorizes risk areas, defines 
risk levels, and provides options for enhanced surveil-
lance and highlight additional public health actions 
to be considered. This paper defines criteria for diag-
nosing the human case of disease and provides public 
health actions and interventions that feed into WNV 
risk assessment [5]. This risk assessment tool, therefore, 
could be very useful for employers to be used for the 
risk assessment process, within the framework of occu-
pational health and safety (OHS), for outdoor workers 
in endemic areas.
The epidemiology of WNV in Europe is complex be-
cause clusters of cases and small outbreaks occurred in 
different Regions and different strains of both WNV 
lineage 1 and lineage 2 were identified, even co-circu-
lating in the same area [12, 13]. 
WNV lineage 1 has been responsible for repeated dis-
ease outbreaks in the countries of the Mediterranean 
basin over the past 50 years. WNV lineage 2, the first 
WNV lineage to be isolated, was believed to be restrict-
ed to sub-Saharan Africa causing a relatively mild fever 
in humans. However, in 2004, it was associated with 
a case of encephalitis in Hungary, and in subsequent 
years, the virus appeared to spread into Austria, Greece 
(2010), Italy (2011) [14] and Romania (2015) [15]. 
The new scenario is the spread of lineage 2 in European 
countries where lineage 1 strain is still circulating creat-
ing favourable conditions for genetic reassortment and 
emergence of new strains [16].
In addition, climatic and environmental conditions 
may influence the seasonality of disease transmission 
due to increased number of mosquito replication cycles 
(consequently also a higher rate of overwintering virus-
carrying mosquitoes) and increased virus transmission 
rates [16]. This may explain why in Italy, results from 
the integrated (veterinary and human) surveillance sys-
tem, during the period 2008-2015, revealed that 91% 
(157/173) of the WNV cases detected occurred in three 
regions (Emilia-Romagna, Lombardy and Veneto) in 
the Po river plain area, with the Emilia-Romagna and 
Veneto regions reporting the highest incidence (1.60 
and 1.46/1000 000 respectively) [17]. Indeed, some cli-
matic factors such as temperature, precipitation, rela-
tive humidity and winds are drivers in WNV epidemiol-
ogy. Climate change is favouring the spreading of WNV 
infection in certain geographical zones [18] and its role 
in the European area remain to be elucidated.
Currently, a recent (2018) national plan for the detec-
tion and control of West Nile and Usutu viruses, that 
integrate human and veterinary (animals and vectors) 
surveillance, is issued and revised annually by the Ital-
ian National Institute of Health, under the supervision 
of the Ministry of Health, according to the observed 
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epidemiological changes [17, 19]. 
This surveillance system that has been set up by 
epidemiologists, should be taken into account by oc-
cupational health stakeholders. Occupational physi-
cians could usefully contribute to this national system, 
actively seeking out symptoms in exposed workers and 
promptly reporting suspected cases.
Addressing timely the mosquito-transmitted diseas-
es is surely a priority for the general population and, 
therefore, has to be considered as a challenge for policy 
makers but, at same time, it constitutes an opportuni-
ty for occupational health stakeholders, as protecting 
workers’ health may strengthen strategies carried out 
by public health stakeholders. Addressing the WNV 
hazard may be an opportunity for integrating the occu-
pational health practice with public health activities to 
boost their respective preventive strategies. Reconnect-
ing public health and occupational health and safety 
may truly improve the health of both general public and 
working populations [20, 21].
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